These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 8957644)

  • 1. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
    Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
    Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
    Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
    van Hattem S; Beerthuizen GI; Kardaun SH
    Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous adverse drug reactions.
    Bettuzzi T; Sanchez-Pena P; Lebrun-Vignes B
    Therapie; 2024; 79(2):239-270. PubMed ID: 37980248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
    Sharma VK; Sethuraman G; Minz A
    Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.
    Azib S; Florin V; Fourrier F; Delaporte E; Staumont-Sallé D
    Clin Exp Dermatol; 2014 Aug; 39(6):723-5. PubMed ID: 24986490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review.
    Novack DE; Braskett M; Worswick SD; Adler BL
    Ann Allergy Asthma Immunol; 2023 May; 130(5):628-636. PubMed ID: 36649833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse drug eruption: the role of drug patch testing.
    Thaiwat S; Rojanapanthu P
    Int J Dermatol; 2023 Jan; 62(1):108-114. PubMed ID: 36300773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
    Mustafa SS; Ostrov D; Yerly D
    Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
    Bouvresse S; Valeyrie-Allanore L; Ortonne N; Konstantinou MP; Kardaun SH; Bagot M; Wolkenstein P; Roujeau JC
    Orphanet J Rare Dis; 2012 Sep; 7():72. PubMed ID: 23009177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.